Logo image of HNR1.DE

HANNOVER RUECK SE (HNR1.DE) Stock Fundamental Analysis

FRA:HNR1 - Deutsche Boerse Ag - DE0008402215 - Common Stock - Currency: EUR

256  +0.2 (+0.08%)

Fundamental Rating

6

Taking everything into account, HNR1 scores 6 out of 10 in our fundamental rating. HNR1 was compared to 37 industry peers in the Insurance industry. HNR1 has an excellent profitability rating, but there are some minor concerns on its financial health. HNR1 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HNR1 was profitable.
HNR1 had a positive operating cash flow in the past year.
HNR1 had positive earnings in each of the past 5 years.
Each year in the past 5 years HNR1 had a positive operating cash flow.
HNR1.DE Yearly Net Income VS EBIT VS OCF VS FCFHNR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

HNR1 has a Return On Assets of 3.10%. This is amongst the best in the industry. HNR1 outperforms 86.49% of its industry peers.
HNR1 has a better Return On Equity (18.63%) than 86.49% of its industry peers.
HNR1's Return On Invested Capital of 3.86% is amongst the best of the industry. HNR1 outperforms 89.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HNR1 is in line with the industry average of 2.19%.
The last Return On Invested Capital (3.86%) for HNR1 is above the 3 year average (2.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.1%
ROE 18.63%
ROIC 3.86%
ROA(3y)2.75%
ROA(5y)2.19%
ROE(3y)17.76%
ROE(5y)14.34%
ROIC(3y)2.97%
ROIC(5y)2.3%
HNR1.DE Yearly ROA, ROE, ROICHNR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

HNR1 has a Profit Margin of 58.98%. This is amongst the best in the industry. HNR1 outperforms 97.30% of its industry peers.
In the last couple of years the Profit Margin of HNR1 has grown nicely.
With an excellent Operating Margin value of 83.94%, HNR1 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
HNR1's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 83.94%
PM (TTM) 58.98%
GM N/A
OM growth 3Y151.64%
OM growth 5Y62.65%
PM growth 3Y132.6%
PM growth 5Y58.31%
GM growth 3YN/A
GM growth 5YN/A
HNR1.DE Yearly Profit, Operating, Gross MarginsHNR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The number of shares outstanding for HNR1 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, HNR1 has less shares outstanding
Compared to 1 year ago, HNR1 has an improved debt to assets ratio.
HNR1.DE Yearly Shares OutstandingHNR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HNR1.DE Yearly Total Debt VS Total AssetsHNR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

The Debt to FCF ratio of HNR1 is 0.81, which is an excellent value as it means it would take HNR1, only 0.81 years of fcf income to pay off all of its debts.
HNR1's Debt to FCF ratio of 0.81 is amongst the best of the industry. HNR1 outperforms 94.59% of its industry peers.
HNR1 has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
HNR1 has a Debt to Equity ratio of 0.38. This is in the better half of the industry: HNR1 outperforms 78.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.81
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
HNR1.DE Yearly LT Debt VS Equity VS FCFHNR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

HNR1 has a Current Ratio of 0.27. This is a bad value and indicates that HNR1 is not financially healthy enough and could expect problems in meeting its short term obligations.
HNR1 has a better Current ratio (0.27) than 75.68% of its industry peers.
A Quick Ratio of 0.27 indicates that HNR1 may have some problems paying its short term obligations.
HNR1 has a Quick ratio of 0.27. This is in the better half of the industry: HNR1 outperforms 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
HNR1.DE Yearly Current Assets VS Current LiabilitesHNR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

HNR1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.44%, which is quite impressive.
HNR1 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.64% yearly.
The Revenue has grown by 60.90% in the past year. This is a very strong growth!
The Revenue for HNR1 have been decreasing by -28.84% on average. This is quite bad
EPS 1Y (TTM)22.44%
EPS 3Y23.67%
EPS 5Y12.64%
EPS Q2Q%38.2%
Revenue 1Y (TTM)60.9%
Revenue growth 3Y-46.83%
Revenue growth 5Y-28.84%
Sales Q2Q%2%

3.2 Future

HNR1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
Based on estimates for the next years, HNR1 will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y10.31%
EPS Next 2Y9.06%
EPS Next 3Y7.4%
EPS Next 5Y8.04%
Revenue Next Year7.87%
Revenue Next 2Y5.34%
Revenue Next 3Y4.95%
Revenue Next 5Y3.83%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HNR1.DE Yearly Revenue VS EstimatesHNR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
HNR1.DE Yearly EPS VS EstimatesHNR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.45, HNR1 is valued correctly.
HNR1's Price/Earnings ratio is a bit cheaper when compared to the industry. HNR1 is cheaper than 62.16% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.86, HNR1 is valued rather cheaply.
HNR1 is valuated reasonably with a Price/Forward Earnings ratio of 11.15.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HNR1 is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of HNR1 to the average of the S&P500 Index (34.94), we can say HNR1 is valued rather cheaply.
Industry RankSector Rank
PE 12.45
Fwd PE 11.15
HNR1.DE Price Earnings VS Forward Price EarningsHNR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HNR1 is valued a bit cheaper than the industry average as 72.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.42
EV/EBITDA N/A
HNR1.DE Per share dataHNR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

HNR1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HNR1 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.21
PEG (5Y)0.98
EPS Next 2Y9.06%
EPS Next 3Y7.4%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.53%, HNR1 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.34, HNR1 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, HNR1 pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.53%

5.2 History

The dividend of HNR1 has a limited annual growth rate of 5.92%.
Dividend Growth(5Y)5.92%
Div Incr Years4
Div Non Decr Years6
HNR1.DE Yearly Dividends per shareHNR1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

HNR1 pays out 40.56% of its income as dividend. This is a bit on the high side, but may be sustainable.
HNR1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP40.56%
EPS Next 2Y9.06%
EPS Next 3Y7.4%
HNR1.DE Yearly Income VS Free CF VS DividendHNR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
HNR1.DE Dividend Payout.HNR1.DE Dividend Payout, showing the Payout Ratio.HNR1.DE Dividend Payout.PayoutRetained Earnings

HANNOVER RUECK SE

FRA:HNR1 (8/21/2025, 5:36:15 PM)

256

+0.2 (+0.08%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners24.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.87B
Analysts77.39
Price Target296.28 (15.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.53%
Yearly Dividend7.57
Dividend Growth(5Y)5.92%
DP40.56%
Div Incr Years4
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.1%
Min EPS beat(2)-15.74%
Max EPS beat(2)-12.47%
EPS beat(4)2
Avg EPS beat(4)1.95%
Min EPS beat(4)-15.74%
Max EPS beat(4)18.73%
EPS beat(8)5
Avg EPS beat(8)1.47%
EPS beat(12)6
Avg EPS beat(12)-2.98%
EPS beat(16)8
Avg EPS beat(16)227.18%
Revenue beat(2)2
Avg Revenue beat(2)1.59%
Min Revenue beat(2)1.18%
Max Revenue beat(2)1.99%
Revenue beat(4)4
Avg Revenue beat(4)1.68%
Min Revenue beat(4)1.18%
Max Revenue beat(4)1.99%
Revenue beat(8)5
Avg Revenue beat(8)-3.55%
Revenue beat(12)7
Avg Revenue beat(12)-4.71%
Revenue beat(16)8
Avg Revenue beat(16)-8.52%
PT rev (1m)-0.18%
PT rev (3m)1.73%
EPS NQ rev (1m)19.65%
EPS NQ rev (3m)2.4%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.39%
Revenue NQ rev (3m)7.35%
Revenue NY rev (1m)2.18%
Revenue NY rev (3m)2.18%
Valuation
Industry RankSector Rank
PE 12.45
Fwd PE 11.15
P/S 8.09
P/FCF 5.42
P/OCF 5.42
P/B 2.56
P/tB 2.57
EV/EBITDA N/A
EPS(TTM)20.57
EY8.04%
EPS(NY)22.97
Fwd EY8.97%
FCF(TTM)47.24
FCFY18.45%
OCF(TTM)47.24
OCFY18.45%
SpS31.65
BVpS100.18
TBVpS99.52
PEG (NY)1.21
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 3.1%
ROE 18.63%
ROCE 4.46%
ROIC 3.86%
ROICexc 3.92%
ROICexgc 4.12%
OM 83.94%
PM (TTM) 58.98%
GM N/A
FCFM 149.27%
ROA(3y)2.75%
ROA(5y)2.19%
ROE(3y)17.76%
ROE(5y)14.34%
ROIC(3y)2.97%
ROIC(5y)2.3%
ROICexc(3y)3.02%
ROICexc(5y)2.35%
ROICexgc(3y)3.16%
ROICexgc(5y)2.55%
ROCE(3y)3.43%
ROCE(5y)2.66%
ROICexcg growth 3Y32.83%
ROICexcg growth 5Y11.08%
ROICexc growth 3Y40.56%
ROICexc growth 5Y15.67%
OM growth 3Y151.64%
OM growth 5Y62.65%
PM growth 3Y132.6%
PM growth 5Y58.31%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.81
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.03
Cash Conversion N/A
Profit Quality 253.09%
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)309.36%
Profit Quality(5y)334.25%
High Growth Momentum
Growth
EPS 1Y (TTM)22.44%
EPS 3Y23.67%
EPS 5Y12.64%
EPS Q2Q%38.2%
EPS Next Y10.31%
EPS Next 2Y9.06%
EPS Next 3Y7.4%
EPS Next 5Y8.04%
Revenue 1Y (TTM)60.9%
Revenue growth 3Y-46.83%
Revenue growth 5Y-28.84%
Sales Q2Q%2%
Revenue Next Year7.87%
Revenue Next 2Y5.34%
Revenue Next 3Y4.95%
Revenue Next 5Y3.83%
EBIT growth 1Y55.42%
EBIT growth 3Y33.8%
EBIT growth 5Y15.74%
EBIT Next Year8.15%
EBIT Next 3Y6.41%
EBIT Next 5YN/A
FCF growth 1Y-1.79%
FCF growth 3Y4.77%
FCF growth 5Y17.76%
OCF growth 1Y-1.79%
OCF growth 3Y4.77%
OCF growth 5Y17.76%